Test Price
2,500 AED✅ Home Collection Available
Medullary Thyroid Carcinoma Mutation Detection Test in Dubai, UAE
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% sensitivity via ISO-accredited targeted RET mutation PCR.
- Premium Logistics: VIP Mobile Phlebotomy & temperature-controlled cold-chain home collection available daily 8 AM to 11 PM.
- Clinical Guidance: Post-test telephonic consultation for result interpretation by our consulting geneticist.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Medullary Thyroid Carcinoma (MTC) Mutation Detection Test is a targeted molecular assay that identifies germline and somatic mutations in the RET proto-oncogene. This test confirms the diagnosis of MTC, distinguishes sporadic from hereditary forms (such as MEN2A/MEN2B), and guides treatment decisions including tyrosine kinase inhibitor therapy and prophylactic thyroidectomy.
| Feature | DNA Labs UAE Test | Closest Alternative |
|---|---|---|
| Precision | 99.9% Diagnostic Sensitivity | ~95% (Sanger Sequencing) |
| Methodology | Targeted RET Mutation PCR | Sanger Sequencing |
| Turnaround Time | 10 Working Days | 15+ Days |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration No. 9294403):
"As a specialist in medical genetics, I understand the anxiety that accompanies genetic testing for hereditary cancer syndromes. This RET mutation test provides definitive molecular evidence to stratify risk and plan intervention. However, it must be correlated with clinical parameters such as calcitonin levels and imaging. The results empower both you and your oncologist to make informed decisions about surveillance or surgery. Always discuss your findings with your treating physician before any change in management."
Pre-Test Advisory
A proper genetics consultation is recommended before testing. Please inform your doctor if you are taking anticoagulants or have a bleeding disorder. You must not discontinue any prescribed medication without professional advice.
Exclusion Criteria & Emergency Red Flags
- This test is not intended for minors under 18 years without legal guardian consent, in compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Patients with active bleeding disorders or those refusing pre-test genetic counseling are not eligible for home collection.
- Emergency: Seek immediate medical care if you develop rapidly enlarging neck mass, difficulty swallowing, or stridor.
Patient FAQ & Clinical Guidance
1. Who should consider this genetic test?
This test is recommended for individuals with a family history of MTC, known RET mutations, or suggestive findings such as elevated calcitonin or thyroid nodules with suspicious ultrasound features. Early detection allows for prophylactic thyroidectomy and familial screening.
2. Is any special preparation required before the blood sample collection?
No fasting is necessary. However, please inform your doctor about all medications, especially anticoagulants. Do not stop any prescribed treatment without consultation. Our mobile phlebotomist will collect a single 4 mL EDTA whole blood sample at your convenience.
3. How will my results impact my clinical management?
A positive RET mutation confirms MTC and helps distinguish hereditary forms (MEN2A/MEN2B). This guides the use of targeted therapies such as tyrosine kinase inhibitors (e.g., vandetanib, cabozantinib) or the timing of total thyroidectomy. A negative result does not entirely exclude MTC; correlate with biochemical markers.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance
This test is performed under the regulatory framework of the Dubai Health Authority (DHA Facility License No. 1143). DNA Labs UAE adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is handled with strict confidentiality. Prior to testing, a Genomics Clinical Information Requisition Form (Form 20) must be completed. The laboratory holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | Medullary Thyroid Carcinoma Mutation Detection Test (RET Gene) |
| Price (AED) | 2,500 AED |
| Turnaround Time | 10 Working Days |
| Sample Type / Matrix | Peripheral whole blood (4 mL, EDTA lavender top) |
| Methodology Used | Targeted RET Mutation PCR |
| ICD-10-CM Code | C73 |
| LOINC Code | 91368-7 |
| DHA Facility License & Address | Lic. No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians